Connor, Clark & Lunn Investment Management Ltd. Abbott Laboratories Put Options Transaction History
Connor, Clark & Lunn Investment Management Ltd.
- $20 Billion
- Q4 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding ABT
# of Institutions
3,303Shares Held
1.34BCall Options Held
9.84MPut Options Held
8.59M-
Vanguard Group Inc Valley Forge, PA169MShares$22.2 Billion0.34% of portfolio
-
Black Rock Inc. New York, NY131MShares$17.3 Billion0.31% of portfolio
-
State Street Corp Boston, MA77.2MShares$10.2 Billion0.35% of portfolio
-
Capital International Investors Los Angeles, CA68MShares$8.96 Billion1.51% of portfolio
-
Capital Research Global Investors Los Angeles, CA54.1MShares$7.13 Billion1.31% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $231B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...